Literature DB >> 8602221

Disruption of the nuclear hormone receptor RORalpha in staggerer mice.

B A Hamilton1, W N Frankel, A W Kerrebrock, T L Hawkins, W FitzHugh, K Kusumi, L B Russell, K L Mueller, V van Berkel, B W Birren, L Kruglyak, E S Lander.   

Abstract

Homozygous staggerer (sg) mice show a characteristic severe cerebellar ataxia due to a cell-autonomous defect in the development of Purkinje cells. These cells show immature morphology, synaptic arrangement, biochemical properties and gene expression, and are reduced in numbers. In addition, sg heterozygotes show accelerated dendritic atrophy and cell loss, suggesting that sg has a role in mature Purkinje cells. Effects of this mutation on cerebellar development have been studied for 25 years, but its molecular basis has remained unknown. We have genetically mapped staggerer to an interval of 160 kilobases on mouse chromosome 9 which was found to contain the gene encoding RORalpha, a member of the nuclear hormone-receptor superfamily. Staggerer mice were found to carry a deletion within the RORalpha gene that prevents translation of the ligand-binding homology domain. We propose a model based on these results, in which RORalpha interacts with the thyroid hormone signalling pathway to induce Purkinje-cell maturation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8602221     DOI: 10.1038/379736a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  160 in total

Review 1.  Action of thyroid hormone in brain.

Authors:  J Bernal
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

Review 2.  Precision in mouse behavior genetics.

Authors:  D Pfaff
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

3.  Topical ROR Inverse Agonists Suppress Inflammation in Mouse Models of Atopic Dermatitis and Acute Irritant Dermatitis.

Authors:  Jun Dai; Min-Kyung Choo; Jin Mo Park; David E Fisher
Journal:  J Invest Dermatol       Date:  2017-07-31       Impact factor: 8.551

4.  Neurogenin 2 regulates progenitor cell-cycle progression and Purkinje cell dendritogenesis in cerebellar development.

Authors:  Marta Florio; Ketty Leto; Luca Muzio; Andrea Tinterri; Aurora Badaloni; Laura Croci; Paola Zordan; Valeria Barili; Ilaria Albieri; François Guillemot; Ferdinando Rossi; G Giacomo Consalez
Journal:  Development       Date:  2012-07       Impact factor: 6.868

Review 5.  Nuclear ataxias.

Authors:  Harry T Orr
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-05       Impact factor: 10.005

6.  RORalpha coordinates reciprocal signaling in cerebellar development through sonic hedgehog and calcium-dependent pathways.

Authors:  David A Gold; Sung Hee Baek; Nicholas J Schork; David W Rose; DeLaine D Larsen; Benjamin D Sachs; Michael G Rosenfeld; Bruce A Hamilton
Journal:  Neuron       Date:  2003-12-18       Impact factor: 17.173

7.  Novel mechanism of nuclear receptor corepressor interaction dictated by activation function 2 helix determinants.

Authors:  Anna N Moraitis; Vincent Giguère; Catherine C Thompson
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

Review 8.  Targeting orphan nuclear receptors for treatment of metabolic diseases and autoimmunity.

Authors:  Thomas P Burris; Scott A Busby; Patrick R Griffin
Journal:  Chem Biol       Date:  2012-01-27

9.  Aberrant development of the suprachiasmatic nucleus and circadian rhythms in mice lacking the homeodomain protein Six6.

Authors:  Daniel D Clark; Michael R Gorman; Megumi Hatori; Jason D Meadows; Satchidananda Panda; Pamela L Mellon
Journal:  J Biol Rhythms       Date:  2013-02       Impact factor: 3.182

Review 10.  Pre-clinical models of neurodevelopmental disorders: focus on the cerebellum.

Authors:  Alexey V Shevelkin; Chinezimuzo Ihenatu; Mikhail V Pletnikov
Journal:  Rev Neurosci       Date:  2014       Impact factor: 4.353

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.